Cargando…

Luteinizing hormone changes in gonadotropin-releasing hormone antagonist protocol in in vitro fertilization cycles: A cross-sectional study

BACKGROUND: Because of the unexpected and often dramatic inhibition of luteinizing hormone (LH) secretion related with the usage of gonadotropin-releasing hormone (GnRH)-antagonist, there has been a probable need for exogenous LH supplementation. There is a basic and clinical evidences that show lat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hosein Rashidi, Batool, Kabodmehri, Roya, Shariat, Mamak, Shahrokh Tehraninejad, Ensieh, Abdollahi, Alireza, Bagheri, Maryam, Hagholahi, Fedieh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Knowledge E 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6661140/ https://www.ncbi.nlm.nih.gov/pubmed/31435601 http://dx.doi.org/10.18502/ijrm.v17i3.4520

Ejemplares similares

Trans dermal estrogen (oestrogel) for endometrial preparation in freeze embryo transfer cycle: An RCT
por: Shahrokh Tehraninejad, Ensieh, et al.
Publicado: (2018)

Luteal phase estradiol versus luteal phase GnRH antagonist administration: their effects on antral follicular size coordination and basal hormonal levels
por: Rashidi, Batool, et al.
Publicado: (2011)

Half-dose, long-acting gonadotropin-releasing hormone agonist (Diphereline) is comparable with daily injections of short-acting gonadotropin-releasing hormone agonist (Suprefact) in IVF/ICSI cycles
por: Tehraninejad, Ensieh Sh., et al.
Publicado: (2010)

Diminished Ovarian Reserve Predisposes to Premature Luteinizing Hormone Surges in Gonadotropin-Releasing Hormone Antagonist Cycles in In vitro Fertilization
por: Kochhar, Puneet Kaur, et al.
Publicado: (2020)

Fixed versus Flexible Gonadotropin Releasing Hormone Antagonist Protocol in Controlled Ovarian Stimulation for Invitro Fertilization in Women with Polycystic Ovary Syndrome
por: Hossein Rashidi, Batool, et al.
Publicado: (2015)

Levonorgestrel-releasing IUD versus copper IUD in control of dysmenorrhea, satisfaction and quality of life in women using IUD
por: Ramazanzadeh, Fatemeh, et al.
Publicado: (2012)

Recombinant FSH Compared to Clomiphene Citrate as the First-Line in Ovulation Induction in Polycystic Ovary Syndrome Using Newly Designed Pens: A Randomized Controlled Trial
por: Hossein-Rashidi, Batool, et al.
Publicado: (2016)

Recombinant luteinizing hormone supplementation in women undergoing in vitro fertilization/ intracytoplasmic sperm injection with gonadotropin releasing hormone antagonist protocol: a systematic review and meta-analysis
por: Xiong, Yujing, et al.
Publicado: (2014)

Progestin vs. Gonadotropin-Releasing Hormone Antagonist for the Prevention of Premature Luteinizing Hormone Surges in Poor Responders Undergoing in vitro Fertilization Treatment: A Randomized Controlled Trial
por: Chen, Qiuju, et al.
Publicado: (2019)

Artificial Endometrial Preparation for Frozen-Thawed Embryo Transfer with or without Pretreatment with Depot Gonadotropin Releasing Hormone Agonist in Women with Regular Menses
por: Azimi Nekoo, Elham, et al.
Publicado: (2015)

The serum follicle stimulating hormone-to-luteinizing hormone ratios can predict assisted reproductive technology outcomes in women undergoing gonadotropin releasing hormone antagonist protocol
por: Zhao, Shen, et al.
Publicado: (2023)

The association of the betatrophin level with metabolic and inflammatory parameters in infertile women with polycystic ovary syndrome: A case-control study
por: Keikha, Fatemeh, et al.
Publicado: (2022)

Luteinizing hormone-like and follicle-stimulating hormone-like activities of equine chorionic gonadotropin β-subunit mutants in cells expressing rat luteinizing hormone/chorionic gonadotropin receptor and rat follicle-stimulating hormone receptor
por: Byambaragchaa, Munkhzaya, et al.
Publicado: (2021)

The enigma of the gonadotropin-releasing hormone pulse frequency governing individual secretion of luteinizing hormone and follicle-stimulating hormone
por: Lambalk, Cornelis B.
Publicado: (2023)

Detection of urinary luteinizing hormone in Japanese black cows after administration of gonadotropin-releasing hormone
por: MIYAZAKI, Tamako, et al.
Publicado: (2021)

Luteinizing hormone and human chorionic gonadotropin: distinguishing unique physiologic roles
por: Choi, Janet, et al.
Publicado: (2014)

SAT-420 Gonadotropin-Releasing Hormone Stimulates Luteinizing Hormone Exocytosis without Elevating Lhb Expression
por: Janjic, Marija, et al.
Publicado: (2019)

GnRH antagonist versus agonist in normoresponders undergoing ICSI: a randomized clinical trial in Iran
por: Tehraninejad, Ensieh, et al.
Publicado: (2011)

Controlled ovarian stimulation with r-FSH plus r-LH vs. HMG plus r-FSH in patients candidate for IVF/ICSI cycles: An RCT
por: Shahrokh Tehraninejad, Ensieh, et al.
Publicado: (2017)

A Comparison of Outcomes from In Vitro Fertilization Cycles Stimulated with Follicle Stimulating Hormone Plus either Recombinant Luteinizing Hormone or Human Menopausal Gonadotropins in Subjects Treated with Long Gonadotropin Releasing Hormone Agonist Protocols
por: Bleau, Nathalie, et al.
Publicado: (2017)

Hinge region mediates signal transmission of luteinizing hormone and chorionic gonadotropin receptor
por: He, Xinheng, et al.
Publicado: (2022)

Scheduling cycles with gonadotropin-releasing hormone antagonist protocol in in vitro fertilization: Is there a scope in batch in vitro fertilization?
por: Gutgutia, Rohit, et al.
Publicado: (2014)

Luteinizing Hormone Secretion during Gonadotropin-Releasing Hormone Stimulation Tests in Obese Girls with Central Precocious Puberty
por: Lee, Hae Sang, et al.
Publicado: (2016)

Comparison Pregnancy Outcomes Between Minimal Stimulation Protocol and Conventional GnRH Antagonist Protocols in Poor Ovarian Responders
por: Pilehvari, Shamim, et al.
Publicado: (2016)

The Effect of COVID-19 Pandemic on Outcome of Assisted Reproductive Technology: A Report from a Single Infertility Center
por: Hossein Rashidi, Batool, et al.
Publicado: (2022)

Luteal estradiol supplementation in gonadotropin-releasing hormone antagonist cycles for infertile patients in vitro fertilization
por: Kwon, Su-Kyoung, et al.
Publicado: (2013)

Novel functions of the luteinizing hormone/chorionic gonadotropin receptor in prostate cancer cells and patients
por: Stroomberg, Hein Vincent, et al.
Publicado: (2020)

Highly sensitive in vitro bioassay for luteinizing hormone and chorionic gonadotropin allowing their measurement in plasma
por: Klett, Danièle, et al.
Publicado: (2021)

Pregnancy outcome in long- versus short-acting gonadotropin-releasing hormone agonist cycles in participants with normal ovarian reserve: An RCT
por: Kabodmehri, Roya, et al.
Publicado: (2023)

Optimal cutoff value of basal anti-mullerian hormone in iranian infertile women for prediction of ovarian hyper-stimulation syndrome and poor response to stimulation
por: Aghssa, Malek Mansour, et al.
Publicado: (2015)

Medroxyprogesterone Acetate versus Gonadotropin-Releasing Hormone Antagonist for the Prevention of Premature Luteinizing Hormone Surge in hyper-responder women undergoing controlled ovarian stimulation for IVF/ICSI Cycles
por: Tandulwadkar, Sunita, et al.
Publicado: (2023)

Do basal Luteinizing Hormone and Luteinizing Hormone/Follicle-Stimulating Hormone Ratio Have Significance in Prognosticating the Outcome of In vitro Fertilization Cycles in Polycystic Ovary Syndrome?
por: Singh, Neeta, et al.
Publicado: (2021)

Do Basal Luteinizing Hormone and Luteinizing Hormone/ Follicle-Stimulating Hormone Ratio have Significance in Prognosticating the Outcome of In vitro Fertilization Cycles in Polycystic Ovary Syndrome?
por: Neeta, Singh, et al.
Publicado: (2021)

Do Basal Luteinizing Hormone and Luteinizing Hormone/Follicle- Stimulating Hormone Ratio have Significance in Prognosticating the Outcome of In vitro Fertilization Cycles in Polycystic Ovary Syndrome?
por: Sookaromdee, Pathum, et al.
Publicado: (2021)

Endocrine profile following stimulation with recombinant follicle stimulating hormone and luteinizing hormone versus highly purified human menopausal gonadotropin
por: Requena, Antonio, et al.
Publicado: (2014)

A comparison of human chorionic gonadotropin and luteinizing hormone releasing hormone on the induction of spermiation and amplexus in the American toad (Anaxyrus americanus)
por: Kouba, Andrew J, et al.
Publicado: (2012)

Human Luteinizing Hormone and Chorionic Gonadotropin Display Biased Agonism at the LH and LH/CG Receptors
por: Riccetti, Laura, et al.
Publicado: (2017)

Clinical development of the oral gonadotropin-releasing hormone antagonist elagolix
por: Chwalisz, Kristof
Publicado: (2023)

Comparison of Vaginal Gel and Intramuscular Progesterone for In vitro Fertilization and Embryo Transfer with Gonadotropin-Releasing Hormone Antagonist Protocol
por: Chi, Hong-Bin, et al.
Publicado: (2018)

A change from gonadotropin releasing hormone antagonist to gonadotropin releasing hormone agonist therapy does not affect the oncological outcomes in hormone sensitive prostate cancer
por: Asakawa, Jumpei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ulm12qiufh0pb2jl7ef98gq1bc